Translating Discovery to Therapy

February 20-22, 2025
The conference will bring together clinicians, researchers, and young investigators to present and discuss current approaches and future directions for translating science to therapy for incontinentia pigmenti (IP). Our goal is to advance our ability to diagnose and manage this rare disease through the development of screening guidelines, effective diagnostics, and novel therapies.

Topics to Advance
IP Diagnosis and Screening
Family Burden – Patient Perspective
Clinical Features of Disease
Sight Threatening Complications
Current Practices and Treatment Protocols
Genetic Aspects of Disease
Molecular Pathways
Development of Novel Therapies
Conference Speakers and Participants
Internationally recognized clinicians, researchers, and young investigators with expertise in developing and applying novel treatments in relationship to IP. Early career investigators are defined as postdoctoral fellows, graduate students, junior faculty (less than 10 years from obtaining terminal degree), and residents.

J. Peter Campbell, MD, MPH

Becky M. Abbott, MPH

Mary Fete MSN, RN, CCM

Connie Chen, MD

Mary Elizabeth Hartnett, MD

Ian Han, MD

Sandra Montezuma, MD

Dorthy Katherine Grange, MD

Reid Wilson, MD, PhD

Aliyah King, BA

Phillip Ehrich

Nancy Arias, MD

Eric Van Otterloo, PhD

Nicole Somani, MD, MPH

Maddison Salois, BS

Saravanan Thangarajan, MDS, MBA

Shirley Parraga, BS

Markus Schwaninger, MD

Emily Cole, MD, MPH

Jacques Monnet

Teresa Faupel

Susanne Emmerich

Jeremie Rosain PhD

Timothy Wright, DDS, MS

Morton F. Goldberg, MD

Audine Berrocal, MD

Xi Chen, MD, PhD

Philip Ferrone, MD

Eric Nudleman, MD, PhD
Registration
Closed
Conference Location
Embassy Suites by Hilton Charlotte Uptown
The conference will be a hybrid meeting with the keynote speakers and key researchers/clinicians present onsite with others invited to participate virtually.
For More Information
Contact Mary Fete, M.S.N., R.N., C.C.M. at 618-566-2020 or mary@nfed.org.
Download Conference Flyer